MOLECULAR PARTNERS AG (MOLN): Price and Financial Metrics
MOLN Price/Volume Stats
| Current price | $5.20 | 52-week high | $12.70 |
| Prev. close | $5.46 | 52-week low | $3.32 |
| Day low | $5.19 | Volume | 29,900 |
| Day high | $5.45 | Avg. volume | 22,108 |
| 50-day MA | $5.41 | Dividend yield | N/A |
| 200-day MA | $5.21 | Market Cap | 209.75M |
MOLN Stock Price Chart Interactive Chart >
MOLECULAR PARTNERS AG (MOLN) Company Bio
Molecular Partners AG engages in the development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. It also develops its products through its brand known as DARPins, which targets specific and potent monoclonal antibodies that offers potential to address existing limitations of antibody drugs. The company products include Abicipar, MP0250/MP0274 and Clinical Trials.
MOLN Price Returns
| 1-mo | -20.85% |
| 3-mo | -16.53% |
| 6-mo | 36.84% |
| 1-year | N/A |
| 3-year | -55.21% |
| 5-year | N/A |
| YTD | 24.40% |
| 2023 | -36.18% |
| 2022 | -65.85% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...